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a b s t r a c t 
The hippocampus is a highly plastic brain structure supporting functions central to human cognition. Morpho- 
logical changes in the hippocampus have been implicated in development, aging, as well as in a broad range of 
neurological and psychiatric disorders. A growing body of research suggests that hippocampal plasticity is closely 
linked to the actions of brain-derived neurotrophic factor (BDNF). However, evidence on the relationship between 
hippocampal volume (HCV) and peripheral BDNF levels is scarce and limited to elderly and patient populations. 
Further, despite evidence that BDNF expression differs throughout the hippocampus and is implicated in adult 
neurogenesis specifically in the dentate gyrus, no study has so far related peripheral BDNF levels to the volumes 
of individual hippocampal subfields. Besides its clinical implications, BDNF-facilitated hippocampal plasticity 
plays an important role in regulating cognitive and affective processes. In the current registered report, we in- 
vestigated how serum BDNF (sBDNF) levels relate to volumes of the hippocampal formation and its subfields in 
a large sample of healthy adults (N = 279, 160 f) with a broad age range (20–55 years, mean 40.5) recruited 
in the context of the ReSource Project. We related HCV to basal sBDNF and, in a subsample (n = 103, 57 f), 
to acute stress-reactive change in sBDNF. We further tested the role of age as a moderator of both associations. 
Contrary to our hypotheses, neither basal sBDNF levels nor stress-reactive sBDNF change were associated with 
total HCV or volume of the dentate gyrus/cornu ammonis 4 (DG/CA4) subfield. We also found no evidence for 
a moderating effect of age on any of these associations. Our null results provide a first point of reference on the 
relationship between sBDNF and HCV in healthy mid-age, in contrast to patient or aging populations. We suggest 
that sBDNF levels have limited predictive value for morphological differences of the hippocampal structure when 
















The human hippocampus displays remarkable potential for struc-
ural plasticity throughout lifetime ( Gonçalves et al., 2016 ; Leuner and
ould, 2010 ; Moreno-Jiménez et al., 2019 ). While debates on the extent∗ Corresponding author(s). 
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 http://creativecommons.org/licenses/by-nc-nd/4.0/ ) f adult neurogenesis in the dentate gyrus of the hippocampus have re-
ently resparked (see Kempermann et al., 2018 for a review), change in
ippocampal structure is well documented as a result of aging ( De Flo-
es et al., 2015 ), chronic stress ( Sapolsky, 2000 ), and in mood disorders
 Cole et al., 2011 ; Malykhin and Coupland, 2015 ; McEwen et al., 2016 ).
 growing body of research suggests a prominent role of brain-derived
eurotrophic factor (BDNF) in mediating such change in hippocampal
olume (HCV) ( Erickson et al., 2012 ; Leal et al., 2015 ; Schmidt and Du-
an, 2007 ). BDNF is the most frequently expressed neurotrophin in the
uman brain, where its release is highly dependent on neuronal activ-ticle under the CC BY-NC-ND license 



































































































































ty ( Greenberg et al., 2009 ). Besides promoting neuronal growth and
ifferentiation, the main function of BDNF is the regulation of synaptic
lasticity ( Huang and Reichardt, 2001 ; Lu et al., 2014 ) throughout the
adult) brain. Substantial research has focused specifically on its fun-
amental action in the hippocampus, including regulation of activity-
ependent long-term potentiation (reviewed in Leal et al., 2017 ). Given
he high degree of plasticity in the hippocampus, and its pivotal role in
emory, learning, and stress- as well as affect regulation ( Bartsch and
ulff, 2015 ), we aim to critically extend evidence on how serum lev-
ls of the plasticity promoter BDNF relate to individual differences in
ippocampal structure in a healthy population, aged 20 to 55. 
In humans, direct links between BDNF and hippocampal plasticity
ave mostly been studied in the context of psychopathology and ag-
ng: Mondelli et al. (2011) found that reduced levels of BDNF mRNA
xpression in psychotic patients as compared to healthy controls were
ssociated with smaller left HCV. Relating peripheral levels of BDNF to
CV, Rizos et al. (2011) found a positive association of serum BDNF
sBDNF) levels with right HCV in psychotic patients, whereas both right
nd left HCV related to sBDNF levels in a small sample of schizophrenia
atients ( Song et al., 2014 ). In non-clinical elderly adults, two studies
elating plasma levels of BDNF to HCV found no significant association
 Driscoll et al., 2012 ; Kim et al., 2015a ). Focusing on BDNF levels in
erum rather than plasma, Erickson et al. (2010) showed a positive cor-
elation with left HCV and marginally with right HCV in 142 participants
ged 59 to 81 (mean age 66.5). sBDNF further mediated the age-related
ecline in HCV in this elderly sample ( Erickson et al., 2010 ). Since the
ippocampi of older adults undergo accelerated aging-related atrophy
 Fraser et al., 2015 ; Raz et al., 2010 ), Erickson et al.’s study (2010) de-
cribes the relation between sBDNF and HCV in a context of heightened
hallenge to hippocampal integrity. Overall, available literature lacks
 crucial baseline model on the relation between sBDNF and HCV in
ealthy, middle-aged adults. 
The above in vivo imaging studies have investigated the plasticity of
he hippocampal formation as a singular structure, averaging across cy-
oarchitecturally distinct subfields. Following the advancement of high-
esolution imaging, studies are now increasingly distinguishing between
ippocampal subfields, notably the cornu ammonis (CA1-4), dentate
yrus (DG), and subiculum (SUB) ( Kulaga-Yoskovitz et al., 2015 ; Vos de
ael et al., 2018 ; Yushkevich et al., 2015 ). Subfield-specific functions
n memory ( Yassa and Stark, 2011 ), as well as differing susceptibility to
he effects of aging and pathology (for a review see Small et al., 2011 )
ave been identified. Mixed results have been found regarding subfield-
pecific atrophy in healthy aging ( De Flores et al., 2015 ; Lowe et al.,
019 ), but recent evidence suggest strongest associations between age
nd DG volume loss ( Adler et al., 2018 ). While it has been suggested
hat BDNF partly mediates aging-related volume loss in the hippocam-
us ( Erickson et al., 2012 ; von Bohlen und Halbach and von Bohlen
nd Halbach, 2018 ), no study has so far investigated if, and how, pe-
ipheral BDNF levels are related to hippocampal subfield volumes. His-
ological post-mortem studies have visualized widespread BDNF gene
xpression (mRNA) and protein distribution in the adult human and rat
ippocampus ( Dugich ‐Djordjevic et al., 1995 ; Murer et al., 1999 ), partic-
larly in the DG (including hilus and fascia dentata) and in the CA (with
arying prevalence in CA1-CA4) ( Phillips et al., 1990 ; Webster et al.,
006 ; Yan et al., 1997 ; Zhang et al., 2007 ). There is also evidence that
RNA and BDNF-responsive TrkB receptors reach peak densities in the
G ( Webster et al., 2006 ), which could suggest that BDNF is most ac-
ive there. Further indirect evidence suggests that the DG could be par-
icularly susceptible to the effects of BDNF: Human post-mortem stud-
es have identified adult neurogenesis in the DG ( Eriksson et al., 1998 ;
palding et al., 2013 ), and reported stable numbers of neural progeni-
ors and immature neurons in the DG across age ( Boldrini et al., 2018 ;
oreno-Jiménez et al., 2019 ). Animal models suggest that BDNF stim-
lates proliferation of adult neural progenitors ( Sairanen et al., 2005 ),
nd central BDNF administration has been found to induce synaptic plas-2 icity in the rodent DG ( Kuipers et al., 2016 ). While these studies exam-
ned central rather than peripheral levels of BDNF, it has been suggested
hat peripheral BDNF levels are highly correlated with hippocampal tis-
ue levels in animals ( Klein et al., 2011 ; Sartorius et al., 2009 ), and with
DNF levels in human cerebrospinal fluid ( Pillai et al., 2010 ). In sum, al-
hough animal and post-mortem studies indicate the DG as particularly
usceptible to the effects of BDNF, potential in vivo associations with
uman peripheral BDNF, in the context of aging or otherwise, remain
o be investigated. 
Complementing research on basal BDNF levels, several studies
emonstrated that BDNF levels can be acutely elevated, and linked such
ncrease to morphological and functional plasticity in the hippocampus
 Griffin et al., 2011 ; Hall et al., 2000 ; Vaynman et al., 2004 ). Animal
odels reveal fast increase in hippocampal BDNF mRNA during stress-
ul challenge ( Marmigère et al., 2003 ), and meta-analytic evidence sug-
ests single sessions of physical exercise to robustly stimulate sBDNF
evels in humans ( Szuhany et al., 2015 ). Recent research extends this
vidence to other acute challenges by showing rapid increase in sBDNF
uring acute psychosocial stress ( Linz et al., 2019 ; Meng et al., 2011 ). 
While a growing body of research has highlighted the close inter-
ction of BDNF and cortisol in modulating (particularly hippocampal)
euronal plasticity ( Gray et al., 2013 ; Jeanneteau et al., 2018 ; Suri and
aidya, 2013 ), evidence on the interplay of BDNF and cortisol regard-
ng hippocampal plasticity in humans is so far limited to their long-term
ffects ( Schoenfeld and Gould, 2012 ). The hippocampus is crucial in in-
ibiting the hypothalamic–pituitary–adrenal (HPA) axis ( Ulrich-Lai and
erman, 2009 ), which is of particular importance in preventing BDNF
ownregulation and hippocampal atrophy caused by excess cortisol sig-
aling ( McEwen et al., 2015 ; Sapolsky, 2000 ). Animal studies further
uggest that adult hippocampal neurogenesis can buffer stress responses
 Snyder et al., 2011 ), and that hippocampal BDNF mediates resilience
o chronic stress ( Taliaz et al., 2011 ). 
Indeed, we recently found an inverse relationship between sBDNF
nd cortisol dynamics during an acute psychosocial stress paradigm
 Linz et al., 2019 ). In particular, higher sBDNF peak levels were associ-
ted with a steeper cortisol recovery. Higher reactive sBDNF levels thus
ppear to be associated with a well-calibrated stress regulatory system,
hich, in turn, critically implies proper functioning of the hippocam-
us in terminating the stress response ( Herman et al., 2003 ). We there-
ore reason that sufficient acute BDNF-related trophic support, which
e found to be in accord with a swift cortisol recovery ( Linz et al.,
019 ), may limit the additive adverse effects of repeated stress expo-
ure. Crucially, the hippocampal structure has been shown to be par-
icularly vulnerable to such adverse effects ( Bartsch and Wulff, 2015 ;
im et al., 2015b ). In line with this reasoning, findings from animal
odels highlight the neuroprotective role of activity-dependent BDNF
elease in adaptively responding to challenge (reviewed in Rothman and
attson, 2013 ), and Leal et al. (2017) suggest that the interplay of BDNF
nd glucocorticoids may be decisive in determining adaptive or mal-
daptive plasticity in stress responses. 
Examining reactive BDNF levels during acute challenge may signal
ndividuals’ resilience or vulnerability to stressful challenge, which in
urn may influence long-term neuronal integrity (Levone et al., 2015;
cEwen, Nasca & Gray, 2016 ). This could provide an intriguing addi-
ional window into the link of sBDNF with HCV in humans besides basal
BDNF. 
In sum, theoretical accounts and a growing body of evidence sug-
est that morphological changes in the hippocampus are linked to the
ctions of BDNF. However, evidence on the association between periph-
ral BDNF and HCV in vivo is lacking, particularly in healthy popula-
ions. No study has to date tested whether sBDNF differentially relates
o the volumes of hippocampal subfields, and whether acutely stimu-
ated and non-stimulated (basal) levels of sBDNF relate to HCV differ-
ntially. Finally, a potential age-moderation of this association has yet
o be tested within a comprehensive age range. 
























































































































r  .1. Current study 
In the current study, we aimed to systematically assess if and how
asal and reactive sBDNF levels relate to total and subfield volumes of
he hippocampus. We examined the association of basal sBDNF and HCV
n a large sample of healthy adults (estimated N = 301, age 20–55, mean
0.7) and for the first time assessed associations with subfield volumes.
urther, in a subsample of the same population (estimated n = 113),
e examined associations with reactive sBDNF levels during an acute
sychosocial stress challenge. Acute stress-reactive BDNF has never been
elated to HCV and may provide a unique insight into the implications
f individual differences in acutely stimulated as opposed to basal BDNF
evels on structural plasticity. 
Data for the current study was collected as part of the ReSource
roject ( Singer et al., 2016 ), a longitudinal mental training study. The
ata assessed here were collected at the pre-intervention baseline mea-
urement and in a control cohort that did not undergo any training. Part
f this data is being examined in another project investigating longitudi-
al effects of mental training on basal sBDNF (Puhlmann et al., in prep.)
nd part was included in the above discussed study relating acute sBDNF
nd cortisol release ( Linz et al., 2019 ). The research questions of the cur-
ent work, however, focus on whether and how individual-differences in
BDNF concentrations are related to unobserved HCV data. None of our
revious analyses examined this association (see also 2.2. data status
nd bias minimization). 
.2. Hypotheses 
Based on previous findings from patients and aging populations
 Erickson et al., 2010 ; Mondelli et al., 2011 ; Rizos et al., 2011 ;
ong et al., 2014 ), we expected higher basal as well as reactive sBDNF
evels to be positively associated with larger hippocampi bilaterally [hy-
otheses A1 (basal sBDNF) & A2 (reactive sBDNF)]. Further, based on
ndirect evidence implicating central BDNF particularly in plasticity of
he DG ( Boldrini et al., 2018 ; Eriksson et al., 1998 ), we hypothesized
hat basal and reactive sBDNF show the strongest associations with DG
olumes [hypotheses B1 (basal sBDNF) & B2 (reactive sBDNF)]. Almost
ll evidence of direct associations between peripheral BDNF and HCV
as been found in populations suffering from aging- or disease-related
CV loss. It is possible that individual BDNF concentrations are more
elevant for HCV maintenance when neurodegenerative processes occur,
uch that associations between peripheral sBDNF and HCV also become
tronger at older age. Therefore, we predicted that the association of
BDNF and total HCV, as well as DG volume, would be stronger for older
articipants [hypotheses C1 (basal sBDNF) & C2 (reactive sBDNF) for
otal HCV; hypotheses D1 (basal sBDNF) & D2 (reactive sBDNF) for DG
olume]. Finally, we predicted that basal and reactive sBDNF would in-
ependently relate to HCV, such that HCV could best be predicted when
sing both measures jointly (hypothesis E; see Supplementary Methods




Three hundred and thirty two healthy participants (age 20–55 years,
ean: 40.7, SD: 9.2) were recruited in the context of the ReSource
roject ( Singer et al., 2016 ). Out of those, n = 242 participants were
ssigned to one of three training cohorts (TCs), and n = 90 to a no-
raining retest control cohort (RCC). All participants were screened for
ental and physical health through questionnaires, including the ICD-
0 Major Depression Inventory (MDI; Bech et al., 2001 ) and the Patient
ealth Questionnaire-D (PHQ-D; Löwe et al., 2002 ; Spitzer et al., 1999 ),
sing predetermined cut-off values as exclusion criteria (for more details
ee Singer et al., 2016 ; chapter 7). Additionally, participants underwent3 wo clinical diagnostic interviews with a trained clinical psychologist
Structured Clinical Interview for DSM-IV Axis-I (SCID-I) ( Wittchen and
fister, 1997 ); SCID-II for Axis-II disorders ( Gibbon et al., 1997 )], and
ere excluded if they fulfilled the criteria for an Axis-I disorder within
he past two years, or the criteria for an Axis-II disorder at any point
n their life. Figure 1 shows the participant flow chart and final sam-
le N for each analysis cluster. For an extensive description of baseline
emographic characteristics, see Singer et al. (2016) , Appendix C2. 
The ReSource Project was registered under the title “Plasticity of the
ompassionate Brain ” with the Protocol Registration System of Clinical-
rials.gov (Identifier: NCT01833104, date of registration: 16/04/2013).
he study was approved by the Research Ethics Committees of the Uni-
ersity of Leipzig (ethic number: 376/12-ff) and the Humboldt Univer-
ity in Berlin (ethic numbers: 2013–02, 2013–29, 2014–10). 
.2. Data collection procedure 
Structural MRI scans and blood for the assessment of basal BDNF
sed in the current study was collected at study baseline (T0) prior to
ny intervention for the training cohorts, or in a control cohort that did
ot undergo any training. Control cohort participants provided basal
BDNF measures at several time points (T0-T3). For the current study,
e used the MRI scan and basal sBDNF sample that was collected clos-
st in time to the respective participant’s reactive sBDNF sample, which
as assessed at only one time-point throughout the study. Specifically,
n a separate testing day, blood samples for the measurement of reac-
ive BDNF were collected during an acute laboratory stress challenge. In
rief, blood samples were drawn 50 min before stress induction (base-
ine measure) and immediately after the termination of the stress test
post-stress sample at approximately 15 min after stressor onset). A more
etailed study protocol is reported in Engert et al. (2017) . In contrast to
wo previous studies conducted in the context of the ReSource Project,
hich reported on a range of psychological and physiological stress
arkers after acute challenge ( Engert et al., 2017 ), and the relation
etween BDNF and cortisol stress reactivity and recovery ( Linz et al.,
019 ), we here exclusively focused on the reactive sBDNF response.
hus, differences in the respective study samples exist due to different
issing data points for different physiological markers. 
.3. Stress induction 
Participants underwent the Trier Social Stress Test (TSST)
 Kirschbaum et al., 1993 ). The TSST is the most frequently used psy-
hosocial laboratory stress protocol to reliably elicit both a physiologi-
al and psychological stress response ( Allen et al., 2014 ). Following an
nticipation phase (15 min in the current study), participants completed
 mock job-interview (5 min) and a difficult mental arithmetic task
5 min) in the presence of a committee of alleged behavioral analysts.
ey features for the efficacy of the TSST are socio-evaluative threat, un-
redictability, and uncontrollability ( Dickerson and Kemeny, 2004 ). 
.4. BDNF assay 
To determine serum levels of brain-derived neurotrophic factor
sBDNF), blood (5.5 ml) was collected into serum vacutainers (Sarst-
dt), allowed to clot for 30 to 45 min, and subsequently centrifuged
t 3500 rpm for 15 min. Serum was frozen at − 80°C until assay. BDNF
oncentrations in serum were determined (at the Department of Clinical
iochemistry, “Aghia Sophia ” Children’s Hospital, Athens, Greece) with
 quantitative sandwich enzyme immunoassay technique (R&D Systems,
nc. Minneapolis, MN, USA), using the recommended buffers, diluents
nd substrates. Optical density of the color reaction was read using a mi-
rotiter plate reader set at 450 nm. sBDNF concentrations (in pg/ml) in
ach sample were calculated according to a standard curve. According to
he manufacturer, the minimum detectable dose (MDD) of total sBDNF
anged from 0.372–1.35 pg/mL, with a mean value of 0.997 pg/mL. The
L.M.C. Puhlmann, R. Linz, S.L. Valk et al. NeuroImage 236 (2021) 118011 
Fig. 1. Participant flow chart. Adapted from Singer et al., (2016) : The Resource Project, chapter 7. The current figure combines numbers from two recruitment 
periods in 2012/2013 and 2013/2014. SCID, structured clinical interview for DSM-5;TC, training cohort; RCC, retest control cohort; TSST, Trier social stress test; 


















a  ntra- and inter-assay coefficients of variation of < 7% were determined
y duplicate analysis of > 6% of randomly selected samples. 
.5. MRI acquisition 
T1-weighted images were acquired on a 3T Siemens Verio scan-
er (Siemens) with a 32-channel head coil, using a three-dimensional
3D) magnetization-prepared rapid gradient-echo (MP-RAGE) sequence
176 sagittal slices; repetition time (TR), 2300 ms; echo time (TE),
.98 ms; inversion time (TI), 900 ms; flip angle, 7°; field of view (FOV),
40 × 256 mm2; matrix, 240 × 256; 1 × 1 × 1 mm3 voxels). All data4 as collected using the same Imaging hardware and console software
Syngo B17). 
.6. Processing of structural data 
Based on the available high-resolution T1-weighted images, we seg-
ented CA1-3, CA4/DG, and subiculum (SUB) using a patch-based algo-
ithm in every subject (for details see Caldairou et al., 2016 ). In brief, the
lgorithm employs a population-based patch normalization relative to a
emplate library ( Kulaga-Yoskovitz et al., 2015 ), which offers good time
nd space complexity. In previous validations, this algorithm has shown





























































































































e  igh segmentation accuracy of hippocampal subfields ( Caldairou et al.,
016 ), and in detecting hippocampal subfield pathology in patients with
pilepsy ( Bernhardt et al., 2016 ). It was furthermore demonstrated that
hese representations can be used to probe subregional functional orga-
ization of the hippocampus ( Vos de Wael et al., 2018 ). Hippocampal
olumes were estimated based on T1w data that were linearly registered
o MNI152, such that intracranial volume was implicitly controlled for.
.7. Segmentation quality control 
To assess successful hippocampus segmentation, an initial quality
heck was conducted by two independent raters, R.L. and L.P. Both
aters were blind to participant characteristics including age, sex, and
vailability and concentration of sBDNF samples. Each segmentation
as rated for quality on a scale of 1–10, with points being subtracted
epending on the severity of detected flaws. One point was subtracted
or minor flaws, e.g. part of a segmentation extends slightly beyond the
ippocampal boundary, or does not cover a small aspect of the hip-
ocampal formation. Two points were subtracted for medium flaws, e.g.
aps between subfield segmentations. Finally, major flaws immediately
ualified for resampling, and included e.g. one or more subfield segmen-
ations being clearly misplaced. Given a minimum of 70% inter-rater re-
iability, segmentation ratings were then averaged and evaluated, with
cores of 5 and lower qualifying for reprocessing with the algorithm.
ollowing this second round of processing, segmentations were rated
gain. Any remaining segmentations with average scores lower than 5
ere excluded from the analysis. We had initially planned to add qual-
ty ratings of the included volumes as regression weights in follow-up
nalyses (see 2.9.2. Significance testing). 
.8. Data status and bias minimization 
Our two predictor variables basal and reactive sBDNF have been pre-
iously observed directly or indirectly as dependent variables. Basal
BDNF was examined directly as part of a project investigating how
BDNF is affected by different types of contemplative mental training
Puhlmann et al., in prep). Reactive sBDNF has been observed indirectly
s part of a project investigating how sBDNF levels during the TSST re-
ate to salivary cortisol, and whether this association is affected by differ-
nt types of contemplative mental training ( Linz et al., 2019 ). HCV data,
ncluding total volume and subfield volumes, was unobserved. The cur-
ent work focuses on the associations between individual differences in
asal or reactive sBDNF and HCVs. Previous observation of intervention
ffects on basal or reactive sBNDF levels did not inform on the relation
o the unobserved hippocampal data. To the best of our knowledge, bias
n the form of model overfitting could therefore only be derived from
ncluding individual-difference variables in our model that have previ-
usly been observed together with sBDNF data. To avoid such bias, we
dopted the analysis approach by Erickson et al. (2010) , limiting the
ovariates of our main analyses to age and sex. 
.9. Statistical analysis 
.9.1. Preprocessing of variables 
The total left and right HCVs were calculated as the sum of the re-
pective subfields. Reactive sBDNF was calculated as the proportion of
pre-TSST) baseline sBDNF. For all measures, data points were excluded
f clearly biologically implausible, meaning outside the range of any pre-
iously reported values, and thus suggested technical errors. If model
esiduals suggested the presence of influential cases, we defined any
BDNF and HCV values that diverged more than three standard devia-
ions from the mean as outliers and winsorized them to the respective
pper or lower boundary of three standard deviations, avoiding data
oss ( Dixon, 1960 ). Additional data processing, for example by means
f a log transformation, were considered depending on residual distri-
utions. 5 .9.2. Significance testing 
Statistical models were calculated in the statistics package R (version
.5.1, R Core Team 2018). Hypotheses were tested by means of frequen-
ist statistics, using multivariate linear models, which were fit using the
unction ’lm’ of the r core package ‘stats’. Our model predictor variables
f interest were basal sBDNF, reactive sBDNF, and age. We additionally
ncluded sex as a covariate in all analyses, since previous studies have
ound sex to covary with BDNF ( Bus et al., 2011 ), and it was included
n Erickson and colleagues’ model. The model testing for a simple re-
ationship of (basal / reactive) sBDNF with HCV (hypotheses A1 & A2)
r subfield volumes (hypotheses B1 & B2) thus included the following
erms: 
HCV i = ß0 + ß1 ∗ age i + ß2 ∗ sex i + ß3 ∗ sBDNF(basal / reactive) i , where
 = subject ID, and ß0 = the intercept 
To evaluate a possible moderating role of age on the relationships of
asal or reactive sBDNF with total HCV (hypotheses C1 & C2), as well
s subfield volumes (hypotheses D1 & D2), we added the interaction
erm sBDNF (basal / reactive) x age to the model. To further address
ypotheses B1 / B2 and D1 / D2, we had initially planned to compare
he strength of potential associations of basal or reactive sBDNF with DG
o the association with CA and SUB (see Stage 1 protocol for details). 
Finally, if either total HCV or any of the subfields’ volume had been
ignificantly related to basal as well as reactive sBDNF in the analyses
escribed above, we would have examined whether a combination of
oth measures would best predict HCV (hypothesis E, see Stage 1 pro-
ocol). For a model-by-model list of all prespecified analyses and corre-
ponding hypotheses, see Supplementary Methods A. 
Following the detection of any significant associations with sBDNF,
e had planned to check the robustness of results by repeating signif-
cant analyses with additional control terms. We had planned to apply
eighted regressions to account for segmentation quality. Automated
egmentations as applied here increase the reproducibility of research,
ut also remain prone to small inaccuracies. To validate that any poten-
ially observed associations were not driven by systematic segmentation
rrors, we had planned to rerun all significant analyses with the addi-
ion of the quality control ratings as weights. Moreover, in the analysis
f basal sBDNF, we had planned to control for the time of day at which
lood was sampled, to account for potential effects of diurnal variation
n resting levels of sBDNF ( Bus et al., 2011 ; Piccinni et al., 2008 ). We
id not expect sBDNF reactivity to be influenced by diurnal fluctua-
ions. Finally, as outlined above, there is evidence that BDNF and corti-
ol interact in modulating hippocampal plasticity. We previously identi-
ed an antagonistic relationship between sBDNF and cortisol dynamics
 Linz et al., 2019 ) in the context of the TSST. Therefore, if identifying a
ignificant association with reactive sBDNF and HCV in any of the pro-
osed model comparisons, we had planned to investigate whether the
xplained variance was independent of individual differences in acute
ortisol dynamics. To this end, we would have added participants’ cor-
isol recovery slopes as a covariate to the respective models and repeat
he comparisons (see also Supplementary Material). The cortisol recov-
ry slope was selected as an indicator of acute cortisol dynamics because
e previously found that it relates to acute peak sBDNF, which is not
qual but related to the reactive sBDNF measure we propose to analyse
ere. 
To ensure adequate interpretation of non-significant outcomes (i.e.
on-significant p-values in null hypothesis tests), we employed equiva-
ence tests ( Wellek, 2010 ). After defining effect size boundaries deemed
quivalent to the absence of a meaningful effect, equivalence tests al-
ow statistical inference on whether an observed effect exceeds a prede-
ned effect size of interest, rather than testing if it equals zero. As re-
ent papers propose that - in the absence of a theoretical limit denoting
n effect as meaningful - feasible equivalence boundaries can be based
n effect size conventions ( Counsell and Cribbie, 2015 ; Lakens, 2017 ),
e predefined our equivalence boundaries corresponding to the lower
nd of what is conventionally referred to as small effect sizes (r ≤ .1;


































































Sample descriptives for data simulation (SD in parentheses). Mean 
( + /-SD) and correlation coefficients of hippocampal volumes are 
based on work by Erickson and colleagues (2010) and were kindly 
provided by Prof. Erickson. Data for age, sBDNF and sex were de- 
rived from our already collected data. lHCV, left hippocampal vol- 
ume; rHCV, right hippocampal volume; sBDNF, serum brain-derived 
neurotrophic factor; SD, standard deviation; BL, baseline (pre TSST). 
Basal BDNF sample Reactive BDNF sample 
N 301 (58% f) 113 (58% f) 
HCV (cm 3 ) 
lHCV 4.82 (0.745) 4.82 (0.745) 
rHCV 4.92 (0.690) 
(0.915 corr. with lHCV) 
4.92 (0.690) 
(0.915 corr. with lHCV) 
Age (yrs) 
Total 40.48 (9.31) 39.98 (8.85) 
f 41.83 (8.91) 41.21 (8.91) 
m 38.63 (9.56) 38.38 (9.56) 
sBDNF (pg / mL) (prop. BL) 
Total 24755 (5998) 1.078 (0.186) 
f 25022 (6268) 1.074 (0.171) 












































ohen, 1992 ). Effect size calculation and equivalence tests were carried
ut using the r package ‘effectsize’ ( Ben-Shachar and Lüdecke, 2020 ). 
.9.3. Outcome-neutral validation tests 
Several conditions had to be met to ensure that the proposed statis-
ical analyses could successfully test our research questions. The statis-
ical assumptions of linear models are based on residual distributions.
hus, we only interpreted model summaries after checking residuals for
ndependence, normality of distribution, and equality of variance, and
fter ruling out potential variance inflation due to (multi)collinearity of
redictors. 
We planned to analyse total HCV by combining left and right vol-
mes, since we expected to find the same pattern of associations with
BDNF across both hemispheres. This assumption was tested separately
or basal and reactive sBDNF, by comparing the respective correlation
ith lHCV to the correlation with rHCV. To this end, we constructed con-
dence intervals (CIs) of the difference in correlations using a formula
hat adjusts for overlapping correlations ( Zou, 2007 ), as implemented
n the function ‘cocor()’ of the r package ‘cocor’ ( Diedenhofen and
usch, 2015 ). Left and right HCVs were combined into total HCV un-
ess the above test indicated a difference in correlations (i.e., zero is
ot in the CI). Based on simulations, this analysis was sufficiently pow-
red ( > 90%) to detect a difference between correlations that diverge by
 ≥ 0.05 for basal sBDNF, or r ≥ 0.08 for reactive sBDNF (see Supple-
entary Figure S2). 
Outcome neutral criteria that have been examined in previous stud-
es included a successful induction of subjective stress and release of the
hysiological stress marker cortisol ( Engert et al., 2017 ), as well as acute
eactivity in sBDNF after stressful challenge ( Linz et al., 2019 ). Below
e outline additional outcome-specific criteria, which determined how
he subfield analysis was conducted. 
.9.4. Multiple comparisons and outcome-specific analysis criteria 
The current study related two measures of sBDNF to HCV and its sub-
elds through a substantial set of analyses. We used a threshold of alpha
 0.05 for the majority of analyses, but applied Bonferroni family-wise
rror rate corrections to control for false positives due to multiple com-
arisons within each family of tests that addressed the same hypothesis
 Shaffer, 1995 ; see Supplementary Methods A). 
First, if analysing the relation of basal and/or reactive sBDNF to left
nd right HCVs separately, we had planned to lower the alpha threshold
o ≤ 0.05/2 for each analysis performed on both hemispheres, reflecting
onferroni correction. Further, given the detection of an overall associ-
tion between basal or reactive BDNF and total HCV, we had planned to
ubsequently analyse the relationship of the respective sBDNF measure
ith all three subfields. While we expected the strongest relationship
ith CA4/DG volume, CA1-3 or SUB could have been associated with
asal or reactive sBDNF, particularly in the presence of an association
ith total HCV. To avoid false positive due to multiple analyses of the
ikely related subfield volumes, the Bonferroni corrected alpha thresh-
ld for these analyses would have been set at ≤ 0.05/3. Alternatively,
f finding no significant main association between sBDNF and the left
r right HCV, we had planned to subsequently only examine the rela-
ion of sBDNF to CA4/DG volume. A significant outcome of this analysis
ould have been interpreted as evidence for a relation between basal
r reactive sBDNF and HCV, even in the absence of an association with
otal HCV. In this case, the Bonferroni corrected alpha threshold would
ave been set to ≤ .05/2 for providing an additional opportunity to de-
ect an association between sBDNF and HCV (in relation to the analysis
f total HCV). Given a significant relationship of sBDNF with CA4/DG
olume, we had planned to use the above proposed interaction model to
ssess whether this relationship was significantly stronger than sBDNF
ssociations with CA1-3 or SUB. Results were not corrected for multiple
omparisons across the two measures of BDNF, which each addressed
ndependent research questions. Basal and reactive BDNF represent dis-
inct temporal dynamics, which we expected to differentially relate to6 CV. While basal sBDNF levels were sampled at rest, reactive sBDNF
evels indicated acute activity-dependent within-subject changes during
hallenge. Basal sBDNF levels should thus provide a relatively stable
easure of general BDNF concentration, while reactive sBDNF levels can
nform BDNF short-term dynamics under challenge. In line with this as-
umption, basal and reactive BDNF levels were uncorrelated ( r = 0.078,
 > 0.25). 
Finally, age moderation analyses complemented the analyses of sim-
le associations, in that they were designed to assess whether associ-
tions with sBDNF were more accurately represented as a function of
articipant age. 
.9.5. Power analysis 
Power was calculated separately for all analyses testing the relation-
hips between basal or reactive sBDNF and total HCV (hypotheses A1,
2, C1 & C2). Power for subfield analyses was not separately calculated,
ince we could not identify and rely on any previous investigation of
BDNF to subfield volume association. 
We opted for a custom simulation approach to adequately represent
he potentially interdependent relation of age, sBDNF and HCV, and to
e able to combine the full information of the already collected data
ith simulated hippocampal data. Total HCV was calculated as the sum
f separately simulated lHCV and rHCV (see Table 1 ). Effect sizes were
ased on Erickson et al. (2010) , who detected r = 0.19 and r = 0.14 cor-
elations of basal sBDNF with lHCV and rHCV, respectively. Stronger
ssociations with basal sBDNF have been detected in healthy control
roups of smaller studies, i.e., a correlation of r = 0.511 with lHCV in
1 controls (m age = 31; Rizos et al., 2011 ; correlation with rHCV not
eported), and r = 0.231 and r = 0.261 correlations with left and right
CV, respectively, in 30 controls, which were, however, not significant
m age = 24.3; Song et al., 2014 ). Considering potential publication bias
nd the comparably small sample sizes of the latter studies, we chose
onservative effect size estimates based on Erickson et al. (2010) , who
eported the smallest effect that was also derived from the largest sample
f healthy, albeit older, individuals. Due to lack of studies from which
e could derive estimated associations of reactive sBDNF with HCV, we
mployed the above effect estimates for our simulations of basal as well
s reactive sBDNF effects. We considered it possible that compared to Er-
ckson and colleagues’ (2010) findings, we would encounter smaller cor-
elations between HCV and age, given our younger sample. To address
his possibility, we modeled expected power based on three different age
orrelations with HCV ( r s for lHCV/rHCV = -0.37/-0.40, -0.32/.0.35, -
.27/.0.30), where the respectively largest associations correspond to
rickson’s findings. 
L.M.C. Puhlmann, R. Linz, S.L. Valk et al. NeuroImage 236 (2021) 118011 
Fig. 2. Power to reject the null hypothesis in hypotheses A1, A2, C1, and C2, based on different strengths of association with lHCV and rHCV. Displayed power 
curves were calculated based on age to HCV associations of r = -0.37 (lHCV) and r = -0.40 (rHCV), as detected by Erickson and colleagues (2010). Considering the 
relative uncertainty regarding which effect sizes may be expected in our hypotheses, particularly regarding age moderation effects, we simulated power for a range 
of possible effect sizes. The plots illustrate to which magnitude of effects our analyses will be sensitive, given our fixed prospective sample sizes of 301 (basal sBDNF) 
and 113 (reactive sBDNF). Red vertical dashed lines indicate the assumed effect strength for lHCV ( r = 0.19), and solid dark blue lines correspond to the assumed 
effect strength for rHCV ( r = 0.14). While data was modelled separately for lHCV and rHCV, the simulated models evaluated effects on total HCV. The code as well 
as the model summary data used to generate the above images can be accessed at the Open Science Framework ( https://osf.io/3p7da/ ). lHCV, left hippocampal 




















Table 1 shows the parameters used in the simulations. Summary
tatistics for HCV were based on Erickson et al., 2010 . Summary statis-
ics for age, sBDNF and sex describe our data collected before Stage 1
ubmission (see Supplementary Methods B for a detailed description of
he simulation). 
Using an alpha level of 0.05, we calculated an estimated power of
00% to detect a simple association of basal sBDNF with HCV ( Fig. 2 ,
ypothesis A1), and of reactive sBDNF with HCV ( Fig. 2 , hypothesis
2), even when modelling smallest age to HCV correlations. For the age
oderation analysis, we assumed fully moderated effects of the same7 izes (i.e., r = 0.19 for lHCV and r = 0.14 for rHCV). We calculated an
stimated power of 100% to detect an age moderation of basal sBDNF
o HCV association for all age to HCV correlations ( Fig. 2 , hypothesis
1), and power of 95.6% / 88.5% / 80.0% to detect an age moderation
f reactive sBDNF to HCV association, depending on the strengths of the
orrelation between age and HCV (larger correlations corresponding to
reater power) ( Fig. 2 , hypothesis C2). The simulation code and model
ummary data used to generate Fig. 2 are publicly shared alongside the
tage 1 protocol. 
L.M.C. Puhlmann, R. Linz, S.L. Valk et al. NeuroImage 236 (2021) 118011 
Table 2 
Descriptives of the analysis samples with basal (left) or reactive 
(right) sBDNF measures. Values shown as mean ( + /-SD); HCV, hip- 
pocampal volume; DG/CA4, dentate gyrus / cornu ammonis 4; CA, 
cornu ammonis 1-3; SUB, subiculum; sBDNF, serum brain-derived 
neurotrophic factor; f, female; m, male. 
Basal sBDNF sample Reactive sBDNF sample 
N 279 (160 f) 103 (57 f) 
Age (yrs) 
Total 40.54 (9.33) 40.46 (8.84) 
f 41.98 (9.00) 41.82 (8.99) 
m 38.61 (9.45) 38.76 (8.44)] 
HCV (cm 3 ) 
Total 12.453 (0.933) 12.396 (0.973) 
Left 6.189 (0.480) 6.154 (0.508) 
Right 6.264 (0.511) 6.2412 (0.520) 
DG/CA4 (cm 3 ) 
Total 1.278 (0.933) 1.283 (0.157) 
Left 0.674 (0.081) 0.675 (0.087) 
Right 0.604 (0.091) 0.609 (0.096) 
CA (cm 3 ) 
Total 7.479 (0.661) 7.422 (0.634) 
Left 3.656 (0.350) 3.616 (0.348) 
Right 3.824 (0.372) 3.807 (0.353) 
SUB (cm 3 ) 
Total 3.699 (0.362) 3.697 (0.398) 
Left 1.860 (0.197) 1.868 (0.212) 
Right 1.838 (0.212) 1.830 (0.215) 
sBDNF (pg /mL) 
Total 24865.42 (6014.17) 1.08 (0.19) 
f 25109.32 (6254.81) 1.07 (0.20) 

























































































y  .9.6. Stage 1 protocol 
The Stage 1 protocol was uploaded after approval and is available
n the Open Science Framework at URL https://osf.io/cdqwu . 
. Results 
.1. Quality control 
Ratings of segmentation quality following the above-specified pro-
edure were sufficiently consistent between the two independent raters
L.P. & R.L.). Of the initial 301 segmentations, 22 segmentations (7.3 %
f the total sample) did not meet the predefined quality standard. Repro-
essing and subsequent reevaluation did not result in improved ratings
f any of these cases, such that they were excluded from the current
nalysis. 
Although cook’s distance values were well below 1 in all models,
isual inspection indicated the presence of two potentially influential
ases in the analysis of basal sBDNF and one in the analysis of reactive
BDNF. Further data exploration revealed one case with unusual high
CV and one with high basal sBDNF, which were both winsorized, in
ine with the prespecified procedure. None of the results were affected
y this transformation. 
.2. Descriptive statistics 
Table 2 displays the descriptives for basal and reactive sBDNF sam-
les. Before hypothesis testing, we explored the association of sBDNF
nd HCV with our main moderator variable, age. In contrast to findings
f Erickson et al. (2010) , we observed no association of HCV with age
 r (277) = .082, p = .172) (see Figure 3 ). Basal sBDNF level correlated
ositively ( r (277) = .157, p = .008), while reactive sBDNF levels were
ot significantly associated with age ( r (101) = .152, p = .123). Age asso-
iations with HCV and basal sBDNF appeared to become more negative
owards older age (median age split, younger: r = .08, p = .32 (HCV),
 = .11, p = .18 (basal sBDNF); older: r = -.11, p = .19 (HCV), r = -.09,8  = .29 (basal sBDNF)). Independent of sBDNF, females displayed signif-
cantly higher HCV in the full sample ( 𝛽 = 357.7, t = 3.07, p = 0.002). 
.3. Confirmatory (pre-registered) analyses 
In accordance with the pre-specified analysis plan, we first tested
hether associations of sBDNF levels with left and right HCV differed
ignificantly. We found no such indications (95% CIs of differences in
orrelations, basal sBDNF: -0.113 to 0.045; reactive sBDNF: -0.116 to
.170) and consequently analysed both hemispheres jointly. 
.3.1. Association of sBDNF with total hippocampal volume (hypotheses 
1-A2, C1-C2) 
Linear models revealed no significant association of basal sBDNF (hy-
othesis A1) or reactive sBDNF (hypothesis A2) with total HCV (A1:
= 0.002, F (1,275) = 0.030, p = .865, 𝜔 2 p = -.003; A2: 𝛽 = -394.93,
 (1, 99) = 0.530, p = .470, 𝜔 2 p = -.005, see Fig. 4 ). Similarly, in test-
ng a potential age moderation of the relationships of basal and reac-
ive sBDNF with HCV (hypotheses C1 and C2), linear models revealed
o significant interaction of age with basal (C1: 𝛽 = 0.001, F (1, 274) =
.268, p = .605, 𝜔 2 p = -.003) or reactive sBDNF (C2: 𝛽 = -47.90, F (1,
8) = 0.638, p = .427, 𝜔 2 p = -.004) in predicting HCV. 
.3.2. Association of sBDNF with DG/CA4 (hypotheses B1-B2, D1-D2) 
Since the above analyses revealed no significant simple or age-
oderated associations of sBDNF with total HCV, subfield analyses
ere limited to DG/CA4, as specified in the analysis plan. Accordingly,
ypotheses B1-2 and D1-2 only examined potential associations with
G/CA4, rather than comparing associations across subfields. 
No evidence was found for a significant association of DG/CA4
ubfield volume with basal (hypothesis B1) or reactive (hypothesis
2) sBDNF levels (B1: 𝛽 = 0.002, F (1, 275) = 1.657, p = .199,
 
2 
p = .002; B2: 𝛽 = -23.40, F(1,99) = 0.078, p = .781, 𝜔 2 p = -.009). 
Similarly, linear models revealed no significant interaction of age
ith basal (hypothesis D1; 𝛽 < < 0.001, F (1, 274) = 0.072, p = .789,
 
2 
p = -.003) or reactive (hypothesis D2; 𝛽 = -13.69, F (1, 98) = 2.218,
 = .140, 𝜔 2 p = .012) sBDNF in predicting DG/CA4 volumes. 
.3.3. Equivalence testing 
Equivalence tests were performed to facilitate interpretation of non-
ignificant null hypothesis significance tests. By statistically comparing
bserved effects to pre-specified effect size boundaries, this approach
an provide support for the absence of – or equivalence to – a prede-
ermined ‘meaningful’ effect ( Lakens, 2017 ). We specified a small effect
ize as meaningful, and consequently tested whether observed effects
ere statistically equivalent to both the upper and lower boundaries
f corresponding partial omega squared values ( 𝜔 2 p > = .01 and 𝜔 2 p 
 = .06), which correspond to a very small and a small-to-medium effect
 Field et al., 2012 ; Kirk, 1996 ). Regarding an association of basal sBDNF
ith total HCV (hypothesis A1), as well as an age-moderated association
f basal sBDNF with DG volume (hypothesis D1), there was statistical
upport for the absence of even a very small meaningful effect. Tests
gainst the upper boundary supported the absence of a small-to-medium
ffect for all hypotheses except hypothesis D2. Accordingly, hypothesis
2 was the only tested association that remained undetermined, mean-
ng that the presence of a meaningful effect equivalent to the specified
oundaries could not be statistically ruled out (for detailed results of
quivalence testing see Supplementary Materials C). 
.4. Exploratory analyses 
.4.1. Joint association of basal and reactive sBDNF with hippocampal 
olume 
Since none of the specified hypotheses revealed significant associa-
ions, we could not pursue hypothesis E. Instead, in an exploratory anal-
sis we examined whether jointly modelling basal and reactive sBDNF
L.M.C. Puhlmann, R. Linz, S.L. Valk et al. NeuroImage 236 (2021) 118011 
Fig. 3. Association of age with total HCV (A, B), DG/CA4 volume (C, D) and with basal (E) and reactive (F) sBDNF levels. Blue lines indicate local polynomial 
(LOESS) regression, grey area represents 95% CIs. HCV, hippocampal volume; DG, dentate gyrus; CA, cornu ammonis 1-3;sBDNF, serum brain-derived neurotrophic 
factor; LOESS, Locally Weighted Scatterplot Smoothing, implemented with the function ‘loess’ of the RCore package. 
Fig. 4. Association of basal sBDNF (A) and reactive sBDNF (B) with total HCV. Blue lines indicate linear regression, grey areas 95% CIs. HCV, hippocampal volume; 
sBDNF, serum brain-derived neurotrophic factor. 
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m  ould explain variance in total HCV or DG/CA4 volume compared to
 model lacking both variables; this was not the case (total HCV: F (2,
8) = 0.805, p = .450; DG/CA4: F (2, 98) = 0.998, p = .373). 
.4.2. Non-linear relationship of age with HCV 
Confirmatory analyses showed no linear relationship of age with
CV in the present sample. Given the considerable age range, we
dditionally explored a potential non-linear association of age and
CV. To this end, we compared the fit of the above reported linear
odel with a model additionally including a quadratic term for age.
dding a quadratic age term did not significantly improve model fit ( F
1,276) = 1.0434, p = .31). 
.4.3. Estimation of HCV with Freesurfer 6.0 
For completeness and to facilitate comparability of the present re-
ults with future and past investigations, we additionally estimated total
CV and subfield volumes by means of a Freesurfer tool for automated
egmentation ( Iglesias et al., 2015 ) for all T1 scans included in the main
nalyses. Results with Freesurfer-based estimates of HCV were consis-
ent with the above confirmatory analyses (section 3.3) and are provided
n Supplementary Materials D. 
. Discussion 
A growing body of research suggests a prominent role of brain-
erived neurotrophic factor (BDNF) in mediating structural change in
he hippocampus. Published studies investigating associations between
eripheral BDNF levels and hippocampal volume (HCV) in vivo in hu-
ans so far focused exclusively on psychopathological or elderly popu-
ations. To provide a first baseline for the relationship of serum BDNF
sBDNF) with HCV in the absence of pronounced hippocampal atro-
hy, the present study investigated this association in a large sample
f healthy, young to middle-aged adults. In aiming to further extend the
iterature, we also investigated associations with hippocampal subfields
nd, above and beyond basal BDNF levels, examined BDNF dynamics in
esponse to an acute psychosocial laboratory stressor. 
Diverging from outcomes with psychopathological and aging popula-
ions ( Erickson et al., 2010 ; Rizos et al., 2011 ; Song et al., 2014 ), we find
o support for an association between basal sBDNF levels and HCV in
ealthy adults aged 20 to 55. Despite the particular significance of BDNF
or dentate gyrus (DG) plasticity ( Boldrini et al., 2018 ; Zagrebelsky et al.,
018 ), there was also no evidence for a specific association with vol-
me of the DG/CA4 subfield. Furthermore, since previous findings in
he present participants showed that sBDNF dynamics inversely related
o endocrine responding during acute stress ( Linz et al., 2019 ), we ad-
itionally tested the possibility that stress-reactive changes in sBDNF
redicted variation in HCV. Like basal levels, stress-reactive changes in
BDNF were unassociated with total HCV and the DG/CA4 subfield. By
dditionally drawing on equivalence tests, these analyses provide statis-
ical support for the absence of sBDNF to HCV associations that are at
east small-to-medium in size in middle-aged healthy adults. 
As outlined in the introduction, the present investigation was de-
igned to contribute to a more complete picture of the conditions under
hich BDNF to HCV associations emerge. In this regard, the above re-
ults do not contradict previous findings in patient populations and older
dults. Rather, they indicate that sBDNF to HCV associations of mean-
ngful size are only observable under conditions of heightened challenge
o neuronal integrity. In other words, a link between sBDNF levels and
CV may more likely be found if hippocampal atrophy – driven by
ging- or disease-related neurodegenerative processes – cannot be com-
ensated by an intact neurotrophic system. Accordingly, the here identi-
ed lack of an association may signal a ceiling effect in sBDNF availabil-
ty, and that trophic support may be sufficient to protect hippocampal
ntegrity in the targeted population. Alternatively, the null findings may
ndicate that the present sample experienced so little age-related atro-10 hy that even individuals with relatively lower BDNF levels did not yet
isplay HCV decline. 
Age moderation analyses targeted the role of BDNF on progressive
ge-related challenge. In the older half of the present sample, age asso-
iations with HCV and basal BDNF were negative, but remained non-
ignificant. Perhaps reflecting this limited age-related decline, moder-
tion analyses revealed that age did not amplify BDNF to HCV associ-
tions. These observations align with longitudinal and cross-sectional
vidence on the structural hippocampus development, which highlights
 different trajectory in comparison to many linearly declining cortical
reas. The hippocampus shows prolonged development at least until the
ge of 30 ( Ostby et al., 2009 ), and thereafter reaches a plateau of rel-
tive stability in mid-life, characterized by only subtle average volume
oss before the age of 50 ( Fjell et al., 2013 ; Raz et al., 2004 ). The sta-
le phase is followed by a non-linear, progressively accelerating decline
or which a recent, exceptionally high-powered study further identified
arked sex differences: while men’s hippocampi started degeneration
arlier, women showed a later onset, but particularly accelerated loss
ates after the critical age of 60 years ( Nobis et al., 2019 ) – a range that
as not captured by the current study. 
An overall positive association of sBDNF and age, as found in
ur data, has previously been reported ( Naegelin et al., 2018 ),
hile other studies in comparable age ranges found no association
 Lommatzsch et al., 2005 ; Trajkovska et al., 2007 ), or described a BDNF
ecline starting around the age of 40 ( Katoh-Semba et al., 2007 ). In
ater life, evidence converges in showing a progressively negative rela-
ionship ( Shimada et al., 2014 ; Ziegenhorn et al., 2007 ). 
Based on both previous and the present results, middle-aged adults
o not seem to experience marked age-related hippocampal atrophy or
DNF decline, which we suggest may be a prerequisite for the detec-
ion of BDNF to HCV associations. In our sample, neither sBDNF nor
CV showed a significant negative association with age, even when
electively examining the older half of participants (median split at
ge 41). One explanation for these results may lie within the specific
articipant sample, which assembled an unusually healthy set of indi-
iduals, despite being recruited from the general population. Because
his investigation relied on baseline data from a longitudinal interven-
ion study, recruitment involved a comprehensive screening procedure
gainst health-related and lifestyle risk factors such as smoking and al-
ohol abuse, as well as drug or medication intake. Additionally, the
resent sample displayed a socio-economic status well above average,
eflected in both substantially higher net income and higher education
han local averages ( Singer et al., 2016 ; Statistisches Bundesamt, 2019 ).
uch socio-demographics are an increasingly recognized predictor of
rain health ( Farah, 2017 , 2018 ; Johnson et al., 2013 ; McEwen and
ianaros, 2010 ) and relate to HCV ( Janowitz et al., 2014 ). Thus, the
resent sample was likely more homogenous and healthier than typical
opulation-based samples, reducing variance in BDNF and HCV. Poten-
ially reflecting this absence of challenge to neuronal integrity, average
asal BDNF levels as well as HCV of the present participant sample can
e considered at the upper end of population-based scores ( Nobis et al.,
019 ; Polacchini et al., 2015 ). It should be noted that there are currently
o valid BDNF reference values ( Naegelin et al., 2018 ), and between-
tudy comparisons suffer from considerable variability in respective
ample collection, treatment and assay ( Polacchini et al., 2015 ). How-
ver, lowest sBDNF levels in our study were well above previously found
inima ( Polacchini et al., 2015 ). Overall, our sBDNF data show a rela-
ively lower variance and range compared to Erickson et al. (2010) and
ther studies in comparable age ranges ( Lommatzsch et al., 2005 ;
oshimura et al., 2016 ). 
Our study was the first to explore reactive sBDNF levels in relation
o HCV. Based on our previous finding of an acute inverse relation of
BDNF and cortisol ( Linz et al., 2019 ), we raised the possibility that
his acute pattern may reflect the established long-term antagonism of
DNF and cortisol regarding neuronal plasticity ( Gray et al., 2013 ). In
ore detail, we argued that increased BDNF peaks during acute stress,



















































































































B  ombined with fast subsequent cortisol recoveries, may reflect a well-
ttuned HPA axis regulation, which critically implies an intact hip-
ocampus. Acute increases in sBDNF during challenging situations may
rovide the necessary short-term trophic support counteracting poten-
ial neuronal strain induced by excess cortisol signaling. However, the
resent findings suggest that lower levels of acute TSST-induced sBDNF
o not signal reduced hippocampal plasticity. While acute sBDNF dy-
amics during stress may hint at differences in individuals’ stress regu-
ation, these differences are not captured in HCV of healthy middle-aged
dults. 
The present study has several limitations. Research suggests that
hile BDNF levels can be reliably assessed in serum, large samples are
eeded to allow meaningful investigations ( Naegelin et al., 2018 ). Our
imulations indicated that basal sBDNF analyses were sufficiently pow-
red, but the analyses of reactive sBDNF were conducted in a smaller
ubsample and no a priori effect estimates could be derived from the
iterature. Likewise, there were no prior reports on the strength of po-
ential associations between sBDNF and subfield volumes. The need for
arge samples arguably relates to the use of peripheral BDNF levels
s an indirect and likely noisier proxy for the actual effects of central
DNF concentrations. Research suggests that peripheral BDNF levels can
rovide a window into specific aspects of brain functioning, showing
hat sBDNF levels are linked to general cognitive function and various
unctional deficits in psychopathology (for a review see Miranda et al.,
019 ). Regarding direct evidence of central to peripheral associations,
DNF levels in blood and hippocampal tissue are correlated in differ-
nt non-human species ( Klein et al., 2011 ; Sartorius et al., 2009 ). In
umans, indications for an alignment between central and peripheral
easures are provided by studies showing correlations of BDNF protein
evels in cerebrospinal fluid and plasma ( Pillai et al., 2010 ), and of serum
DNF with in vivo levels of a neuronal integrity marker ( Lang et al.,
007 ). Nonetheless, the precise extent to which human central and pe-
ipheral BDNF concentrations correspond is unknown. Finally and more
enerally, it remains debated to what extent greater volume of brain
tructures reflects greater integrity or improved function (e.g., Van Pet-
en, 2004 ). Measures of functional activity or connectivity may provide
ore sensitive estimates of hippocampal functioning, particularly for
opulations that do not display marked neuronal atrophy. 
onclusion 
The null findings of the present study provide a baseline for future in-
estigations with vulnerable samples. Although we expected to capture
he onset of age-related decline and related compensatory mechanisms,
uch challenge appeared to be insignificant even at the upper end of
he present age range. Based on this outcome, future studies may want
o investigate the emergence of BDNF to HCV associations by track-
ng BDNF levels and neuronal integrity in healthy individuals at risk
or developing conditions associated with accelerated neurodegenera-
ion. Our results should not discourage future subfield-specific investi-
ations or further explorations of reactive sBDNF levels in patient or
lder populations, considering also that hippocampal sub-regions dis-
lay differential trajectories throughout the lifespan ( Daugherty et al.,
016 ). At present, there is great interest in peripheral BDNF as a predic-
ive marker for various conditions associated with neurodegeneration
 Qin et al., 2017 ), cognitive deficits ( Xie et al., 2020 ), or affective dis-
rders ( Fernandes et al., 2014 ; Molendijk et al., 2014 ; Polyakova et al.,
015 ). While there are, to our knowledge, no reports on BDNF to HCV
ssociations in a healthy mid-aged sample, previous null findings may
ave remained unpublished due to dominant publishing norms and in-
entive schemes ( Nosek et al., 2012 ). Our findings thus add to a more
omplete picture of the utility of peripheral BDNF in signaling brain
tructure differences, by suggesting limited predictive value for HCV in
ealthy mid-aged adults. 11 cknowledgements 
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